Weiss Ratings Reaffirms “Sell (E+)” Rating for SCWorx (NASDAQ:WORX)

SCWorx (NASDAQ:WORX)‘s stock had its “sell (e+)” rating restated by Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen raised shares of SCWorx to a “sell” rating in a research report on Saturday, June 14th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, SCWorx has an average rating of “Sell”.

SCWorx Trading Up 1.3%

WORX opened at $0.31 on Wednesday. The stock has a market capitalization of $2.44 million, a P/E ratio of -0.29 and a beta of 2.60. SCWorx has a 12 month low of $0.26 and a 12 month high of $3.31. The firm’s fifty day simple moving average is $0.31 and its 200 day simple moving average is $0.46.

SCWorx (NASDAQ:WORX) last posted its quarterly earnings data on Thursday, August 14th. The company reported ($0.44) EPS for the quarter. The company had revenue of $0.68 million during the quarter. SCWorx had a negative net margin of 105.74% and a negative return on equity of 58.42%.

SCWorx Company Profile

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.